MENU
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Passage Bio (PASG) Ownership - Who owns Passage Bio?

Passage Bio Inc is a genetic medicines company... Show more

Profile

Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.82M
P/E Ratio
0.18
Total Cash
57.63M
Projected Growth
N/A
Total Debt
24.73M
Revenue
N/A
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash/Share
18.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PASG
Capitalization
22.8M
P/E Ratio
0.18
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash
57.6M
Total Cash/Share
18.13
Total Debt
24.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
38.3M
P/B Ratio
0.60
Cash Flow
N/A
Earnings
39.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
3.05
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-52.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-55.58
Shares Held By Institutions
11.3M
Shares Outstanding - Current
3.18M
Total Liabilities
40.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-36.696
View a ticker or compare two or three
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PASG showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com